J. Mark Gidley > White & Case LLP > Washington DC, United States > Lawyer Profile

White & Case LLP regularly represents clients in high-stakes litigation, particularly class actions concerning consumer protection claims and antitrust conspiracy allegations. The team is well versed in pharmaceutical antitrust matters with a client roster including Pfizer and Samsung Bioepis, whilst continuing to grow its fintech and technology antitrust capabilities. Mark Gidley chairs the practice from Washington DC, offering significant experience in trying criminal and civil antitrust cases, while Christopher Curran often handles precedent setting matters. New York-based Jack Pace often acts as lead counsel for pharmaceutical companies and manufacturers as well as leading fintech companies, recently acting as lead drafter in the briefing behind victories for Apex Clearing Corporation, obtaining the dismissal of class action antitrust complaints. Kathryn Jordan Mims’ practice in DC focuses on class actions, merger enforcement actions and government enforcement actions. Head of the global pharmaceuticals and healthcare group, Peter Carney regularly represents pharmaceutical clients in litigation involving patent settlement agreements, product hopping and switching strategies in federal court and before the FTC. Situated in New York, Martin Toto is recognized as a leading attorney with experience in defending clients in price fixing jury trials while Kristen O’Shaughnessy defends global companies in class action and commercial litigation, with a particular expertise in the pharmaceutical industry.

White & Case LLP‘s cartel team regularly represents corporates and individuals in high-profile civil and criminal cartel proceedings, including bet-the-company litigation for major pharmacy industry players. Clients from a range of jurisdictions and industries, including life sciences, financial services, and auto parts, seek the firm out for its cartel defense capabilities as well as its expertise in multijurisdictional litigation and investigations. The firm is a litigation powerhouse with a remarkably strong track record in disposing civil and criminal claims in court or on appeal, both in the US and in global cartel cases. The team, based in Washington DC unless otherwise stated, is headed by significantly experienced cartel litigator Mark Gidley. He is supported by Peter Carney, whose practice focuses on healthcare and pharma-related antitrust litigation, as well as Christopher Curran, whose litigation and defense of an amnesty agreement was the first of its kind. Trial attorney J. Frank Hogue is regularly involved in enforcement proceedings and class action defense. Adam Acosta  is a litigator focusing on complex antitrust litigation and government investigations, while New York-based Robert Milne and Raj Gandesha also receive praise for their antitrust expertise.